Top 5 Drug Type | Count |
---|---|
Antibody | 13 |
Monoclonal antibody | 7 |
Enzyme | 3 |
Small molecule drug | 2 |
Colony-stimulating factors | 2 |
Target |
Mechanism IL-11RA stimulants [+1] |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date18 Apr 2008 |
Target |
Mechanism PLG stimulants |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date30 Sep 2007 |
Target |
Mechanism EPO receptor modulators |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Jan 2003 |
Start Date16 Nov 2022 |
Sponsor / Collaborator |
Start Date14 Apr 2022 |
Sponsor / Collaborator |
Start Date13 Apr 2022 |
Sponsor / Collaborator |